Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Clinical Pharmacokinetics
|
August 19, 1999
Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients
R Gieschke, B Fotteler, N Buss, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1988
Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine
A Mallet, F Mentré, J L Steimer, et al.
Therapie
|
January 1, 1986
[Mean residence time in the body. A new pharmacokinetic parameter?]
A M Taburet, J L Steimer, D Doucet, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
April 1, 1996
Sparse sampling for assessment of drug exposure in toxicological studies
P Burtin, F Mentre, J van Bree, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1982
A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation
J L Steimer, Y Plusquellec, A Guillaume, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 27, 2002
Population pharmacokinetic analysis of the major metabolites of capecitabine
R Gieschke, B Reigner, K S Blesch, et al.
Clinical Pharmacology and Therapeutics
|
June 29, 2000
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone
K Jorga, L Banken, B Fotteler, et al.
British Journal of Clinical Pharmacology
|
December 22, 1999
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
K Jorga, B Fotteler, L Banken, et al.
Arzneimittel-Forschung
|
January 1, 1984
Isoniazid plasma and lymph kinetics after intravenous injection in dogs
M Blanc, J L Steimer, C Boyer, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
October 1, 1993
A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers
P Francheteau, J L Steimer, H Merdjan, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Clinical Pharmacokinetics
|
August 19, 1999
Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients
R Gieschke, B Fotteler, N Buss, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
June 1, 1988
Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine
A Mallet, F Mentré, J L Steimer, et al.
Therapie
|
January 1, 1986
[Mean residence time in the body. A new pharmacokinetic parameter?]
A M Taburet, J L Steimer, D Doucet, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
April 1, 1996
Sparse sampling for assessment of drug exposure in toxicological studies
P Burtin, F Mentre, J van Bree, et al.
Journal of Pharmaceutical Sciences
|
March 1, 1982
A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation
J L Steimer, Y Plusquellec, A Guillaume, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 27, 2002
Population pharmacokinetic analysis of the major metabolites of capecitabine
R Gieschke, B Reigner, K S Blesch, et al.
Clinical Pharmacology and Therapeutics
|
June 29, 2000
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone
K Jorga, L Banken, B Fotteler, et al.
British Journal of Clinical Pharmacology
|
December 22, 1999
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies
K Jorga, B Fotteler, L Banken, et al.
Arzneimittel-Forschung
|
January 1, 1984
Isoniazid plasma and lymph kinetics after intravenous injection in dogs
M Blanc, J L Steimer, C Boyer, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
October 1, 1993
A mathematical model for dynamics of cardiovascular drug action: application to intravenous dihydropyridines in healthy volunteers
P Francheteau, J L Steimer, H Merdjan, et al.
Page
of 5